<--- Back to Details
First PageDocument Content
Pharmacology / Food and Drug Administration / Unique Device Identification / Medical equipment / Pharmaceutical industry / Medical device / Adverse event / Postmarketing surveillance / Patient safety / Medicine / Health / Clinical research
Pharmacology
Food and Drug Administration
Unique Device Identification
Medical equipment
Pharmaceutical industry
Medical device
Adverse event
Postmarketing surveillance
Patient safety
Medicine
Health
Clinical research

Identifying Real-world Human Factors Issues

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 1,10 MB

Share Document on Facebook

Similar Documents

Pharmaceuticals policy / Health / Medical research / Pharmacovigilance / European Medicines Agency / EudraLex / European Directive on Traditional Herbal Medicinal Products / Postmarketing surveillance / Adverse effect / Qualified Person Responsible For Pharmacovigilance / EudraVigilance

COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 10 December 2008 SECVolume I

DocID: 1qH6O - View Document

Medicine / Clinical research / Pharmaceuticals policy / Medical technology / Medical equipment / Postmarketing surveillance / Research / Medical device / Administrative guidance

IMDRF Presentation - WHO update

DocID: 1q40h - View Document

Medical equipment / Clinical research / Medical technology / Pharmaceuticals policy / Clinical trials / Postmarketing surveillance / Medical device / Global Harmonization Task Force / Interactive television / Validation

IMDRF Presentation - Update on WHO work

DocID: 1oBkV - View Document

Health / Medicine / Pharmaceuticals policy / Drug safety / Pharmacy / Pharmacovigilance / EudraLex / Qualified Person Responsible For Pharmacovigilance / Postmarketing surveillance / Pharmacology / Pharmaceutical sciences / Clinical research

Microsoft Word - Volume IX ENdoc

DocID: 1g2y9 - View Document

Pharmaceutical industry / Health / Pharmaceuticals policy / Clinical research / Pharmacovigilance / Good manufacturing practice / Postmarketing surveillance / Pharmaceutical sciences / Pharmacy / Pharmacology

Kyrgyzstan Assessment of Pharmaceutical Data Disclosure Disclosure Status of Pharmaceutical Sector Data Part of Component 1 of the MeTA Baseline Assessments Kyrgyz Republic

DocID: 1fUrF - View Document